Avience Biomedicals Limited (NSE:AVIENCE)
India · Delayed Price · Currency is INR 287.40
-2.75 (-0.95%)
At close: Oct 7, 2026
Avience Biomedicals Revenue
In the fiscal year ending March 31, 2026, Avience Biomedicals had annual revenue of 525.16M INR with 15.80% growth. Avience Biomedicals had revenue of 122.35M in the quarter ending March 31, 2025. That makes Avience Biomedicals the world's 39,660th largest company by revenue and 3,707th in India.
Revenue
525.16M
Revenue Growth
+15.80%
P/S Ratio
3.00
Revenue / Employee
n/a
Employees
65
Market Cap
1.58B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 525.16M | 71.66M | 15.80% |
| Mar 31, 2025 | 453.50M | 213.86M | 89.24% |
| Mar 31, 2024 | 239.64M | 130.38M | 119.32% |
| Mar 31, 2023 | 109.26M | 7.79M | 7.68% |
| Mar 31, 2022 | 101.48M | 90.14M | 795.59% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shreyans Industries | 6.29B |
| Integra Essentia | 5.07B |
| Brand Concepts | 3.56B |
| Alpine Texworld | 3.43B |
| Shubhshree Biofuels Energy | 2.02B |
| Agastya Energy and Infrastructure | 1.56B |
| Goldkart Jewels | 1.17B |
| Avio Smart Market Stack | 1.07B |